SUTENT is used to treat GIST (gastrointestinal stromal tumor). This is a rare cancer of the stomach, bowel, or esophagus. SUTENT is used when the medicine Gleevec® (imatinib mesylate) did not stop the cancer from growing or when you cannot take Gleevec.
Gleevec is a registered trademark of Novartis AG.

SUTENT may slow or stop some cancers, such as GIST. It works by blocking 2 basic
processes that cause tumors to grow and spread. These processes are called
proliferation and
angiogenesis.
This is when a cell divides, creating 2 cells where there used to be only 1. Like
the other cells in your body, cancer cells divide. The difference is that cancer
cells divide more times than they should, forming a tumor. SUTENT may help slow
down this process.
This is when new blood vessels form. These new blood vessels give tumors the nutrients
and oxygen they need to grow. SUTENT may help stop this process.
SUTENT may help stop proliferation and angiogenesis by blocking the signals that
cause them. Without these 2 processes, tumors cannot grow.